Ever since the ureteral stent design was fitted with a curl on both sides to prevent it from migrating up or down the ureter some 40 years ago, its use has gained tremendous momentum, aiding in the rise and evolution of endourology and has confidently kept its place in modern time urology. Over the past four decades, several designs, coating and biomaterials have been developed, trying to reduce infection, encrustation and other stent related symptoms. As the ideal stent has not yet been discovered, different ways of helping patients with their complaints have been researched. This review will cover these aspects of stent use in urolithiasis.
. [J]. Asian Journal of Urology, 2018, 5(4): 274-286.
Matthias Beysens,Thomas O. Tailly. Ureteral stents in urolithiasis. Asian Journal of Urology, 2018, 5(4): 274-286.
Shoemaker IV GE . An improvement in the technique ofcatheterization of the ureter in the female. Ann Surg 1895; 22:650e4.
doi: 10.1097/00000658-189507000-00077
pmid: 17860231
Hepperlen TW, Mardis HK, Kammandel H . Self-retained internalureteral stents: a new approach. J Urol 1978; 119:731e4.
pmid: 77917
[6]
Türk C , Pet?ík A, Sarica K, Seitz C, Skolarikos A, Straub M,et al. EAU guidelines on interventional treatment for urolithiasis. Eur Urol 2016; 69:475e82.
doi: 10.1016/j.eururo.2015.07.041
pmid: 26344917
[7]
Pearle MS, Pierce HL, Miller GL, Summa JA, Mutz JM, Petty BA , et al. Optimal method of urgent decompression ofthe collecting system for obstruction and infection due toureteral calculi. J Urol 1998; 160:1260e4.
doi: 10.1016/S0022-5347(01)62511-4
pmid: 9751331
[8]
Mokhmalji H, Braun PM, Martinez Portillo FJ, Siegsmund M, Alken P, Köhrmann KU . Percutaneous nephrostomy versusureteral stents for diversion of hydronephrosis caused bystones: a prospective, randomized clinical trial. J Urol 2001; 165:1088e92.
doi: 10.1016/S0022-5347(05)66434-8
pmid: 11257644
[9]
Sammon JD, Ghani KR, Karakiewicz PI, Bhojani N, Ravi P, Sun M , et al. Temporal trends, practice patterns, andtreatment outcomes for infected upper urinary tract stonesin the United States. Eur Urol 2013; 64:85e92.
doi: 10.1016/j.eururo.2012.09.035
pmid: 2303167720
[10]
Goldsmith ZG, Oredein-McCoy O, Gerber L, Bañez LL, Sopko DR, Miller MJ , et al. Emergent ureteric stent vspercutaneous nephrostomy for obstructive urolithiasis withsepsis: patterns of use and outcomes from a 15-year experience.BJU Int 2013; 112:E122e8.
doi: 10.1111/bju.12161
pmid: 23795789
[11]
Elsheemy MS, Shouman AM, Shoukry AI, Elshenoufy A, Aboulela W, Daw K , et al. Ureteric stents vs percutaneousnephrostomy for initial urinary drainage in children withobstructive anuria and acute renal failure due to uretericcalculi: a prospective, randomised study. BJU Int 2015; 115:473e9.
doi: 10.1111/bju.12768
pmid: 24698195
[12]
Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP , et al. Surgical management of stones: AmericanUrological Association/Endourological Society Guideline,PART II. J Urol 2016: 1e9.
doi: 10.1016/j.juro.2016.05.091
pmid: 27238616
[13]
Denstedt JD, Wollin TA, Sofer M, Nott L, Weir M , D’AHoney RJ. A prospective randomized controlled trialcomparing nonstented versus stented ureteroscopic lithotripsy. J Urol 2001; 165:1419e22.
doi: 10.1016/S0022-5347(05)66320-3
pmid: 11342889
[14]
Wang H, Man L, Li G, Huang G, Liu N, Wang J . Meta-analysisof stenting versus non-stenting for the treatment of ureteralstones. PLoS One 2017; 12:e0167670.
doi: 10.1371/journal.pone.0167670
pmid: 28068364
[15]
Muslumanoglu AY, Fuglsig S, Frattini A, Labate G, Nadler RB, Martov A , et al. Risks and benefits of postoperative double-Jstent placement after ureteroscopy: results from the ClinicalResearch Office of Endourological Society UreteroscopyGlobal Study. J Endourol 2017; 31:446e51.
[16]
Giusti G, Proietti S, Villa L, Cloutier J, Rosso M, Gadda GM , et al. Current standard technique for modern flexible ureteroscopy:tips and tricks. Eur Urol 2016; 70:188e94.
doi: 10.1016/j.eururo.2016.03.035
pmid: 27086502
[17]
Astroza G, Catalán M, Consigliere L, Selman T, Salvadò J, Rubilar F . Is a ureteral stent required after use of ureteralaccess sheath in presented patients who undergo flexibleureteroscopy? Cent Eur J Urol 2017; 70:88e92.
doi: 10.5173/ceju.2016.919
pmid: 28461995
[18]
Torricelli FC, De S, Hinck B, Noble M, Monga M . Flexibleureteroscopy with a ureteral access sheath: when to stent? Urology 2014; 83:278e81.
[19]
Sirithanaphol W, Jitpraphai S, Taweemonkongsap T, Nualyong C, Chotikawanich E . Ureteral stenting after flexibleureterorenoscopy with ureteral access sheath; Is it reallyneeded?: A prospective randomized study. J Med Assoc Thail2017;100:S174e8.
[20]
Seklehner S, Sievert K, Lee R, Engelhardt PF, Riedl C, Kunit T . A cost analysis of stenting in uncomplicated semirigidureteroscopic stone removal. Int Urol Nephrol 2017; 49:753e61.
doi: 10.1007/s11255-017-1538-6
pmid: 28197765
[21]
Staubli SEL, Mordasini L, Engeler DS, Sauter R, Schmid HP, Abt D . Economic aspects of morbidity caused by ureteralstents. Urol Int 2016; 97:91e7.
doi: 10.1159/000443379
pmid: 26795568
[22]
Shigemura K, Yasufuku T, Yamanaka K, Yamahsita M, Arakawa S, Fujisawa M . How long should double J stent bekept in after ureteroscopic lithotripsy? Urol Res 2012; 40:373e6.
doi: 10.1007/s00240-011-0426-2
pmid: 21927861
[23]
Nevo A, Mano R, Baniel J, Lifshitz DA . Ureteric stent dwellingtime: a risk factor for post-ureteroscopy sepsis. BJU Int 2017; 120:117e22.
doi: 10.1111/bju.13796
pmid: 28145037
[24]
Shen P, Jiang M, Yang J, Li X, Li Y, Wei W , et al. Use ofureteral stent in extracorporeal shock wave lithotripsy forupper urinary calculi: a systematic review and meta-analysis. J Urol 2011; 186:1328e35.
doi: 10.1016/j.juro.2011.05.073
pmid: 21855945
[25]
Al-Awadi KA, Abdul Halim H, Kehinde EO, Al-Tawheed A . Steinstrasse: a comparison of incidence with and without Jstenting and the effect of J stenting on subsequent management. BJU Int 1999; 84:618e21.
[26]
Fuller TW, Rycyna KJ, Ayyash OM, Ferroni MC, Mitchell CR, Ohmann E , et al. Defining the rate of primary ureteroscopicfailure in unstented patients: a multi-institutional study. JEndourol 2016; 30:970e4.
doi: 10.1089/end.2016.0304
pmid: 27301268
[27]
Hubert KC, Palmer JS . Passive dilation by ureteral stentingbefore ureteroscopy: eliminating the need for active dilation. J Urol 2005; 174:1079e80.
doi: 10.1097/01.ju.0000169130.80049.9c
pmid: 16094062
[28]
Assimos D, Crisci A, Culkin D, Xue W, Roelofs A, Duvdevani M , et al. Preoperative JJ stent placement in ureteric and renalstone treatment: results from the Clinical Research Office ofEndourological Society (CROES) Ureteroscopy (URS) GlobalStudy. BJU Int 2016; 117:648e54.
doi: 10.1111/bju.13250
pmid: 26237735
[29]
Yang Y, Tang Y, Bai Y, Wang X, Feng D, Han P . Preoperativedouble-J stent placement can improve the stone-free ratefor patients undergoing ureteroscopic lithotripsy: a systematicreview and meta-analysis. Urolithiasis 2017: 1e7.
doi: 10.1007/s00240-017-1012-z
pmid: 29094191
[30]
Kawahara T, Ito H, Terao H, Ishigaki H, Ogawa T, Uemura H , et al. Preoperative stenting for ureteroscopic lithotripsy for alarge renal stone. Int J Urol 2012; 19:881e5.
doi: 10.1111/j.1442-2042.2012.03046.x
pmid: 22583110
[31]
Joshi HB, Okeke A, Newns N, Keeley FX, Timoney AG . Characterizationof urinary symptoms in patients with ureteralstents. Urology 2002; 59:511e6.
doi: 10.1016/S0090-4295(01)01644-2
pmid: 11927301
[32]
Koprowski C, Kim C, Modi PK, Elsamra SE . Ureteral stentassociatedpain: a review. J Endourol 2016; 30:744e53.
doi: 10.1089/end.2016.0129
pmid: 27125392
[33]
Sameh WM, Eid AA . Pressure transmission through uretericstents: a novel in vivo human study. Urology 2012; 79:766e70.
doi: 10.1016/j.urology.2011.10.056
pmid: 22245299
[34]
Leibovici D, Cooper A, Lindner A, Ostrowsky R, Kleinmann J, Velikanov S , et al. Ureteral stents: morbidity and impact onquality of life. Isr Med Assoc J 2005; 7:491e4.
doi: 10.1007/s00108-005-1474-x
pmid: 16106772
[35]
Joshi HB, Newns N, Stainthorpe A , MacDonagh RP, Keeley FX,Timoney AG. Ureteral stent symptom questionnaire: developmentand validation of a multidimensional quality of lifemeasure. J Urol 2003; 169:1060e4.
doi: 10.1097/01.ju.0000049198.53424.1d
pmid: 12576846
[36]
Giannarini G, Keeley FX, Valent F, Milesi C, Mogorovich A, Manassero F , et al. The Italian linguistic validation of theUreteral Stent Symptoms Questionnaire. J Urol 2008; 180:624e8.
doi: 10.1016/j.juro.2008.04.022
pmid: 18554654
[37]
Park J, Shin DW, You C, Chung KJ, Han DH, Joshi HB , et al. Cross-cultural application of the Korean version of UreteralStent Symptoms Questionnaire. J Endourol 2012; 26:1518e22.
doi: 10.1089/end.2012.0235
pmid: 22662966
[38]
Sanguedolce F, Millán-Rodriguez F, Santillana-Altimira JM, Fantova-Alonso A, Sánchez-Martín FM, Angerri-Feu O , et al. The Spanish linguistic validation of the Ureteral StentSymptom Questionnaire. J Endourol 2014; 28:237e42.
doi: 10.1089/end.2013.0325
pmid: 24032342
[39]
Puichaud A, Larré S , Bruyère F, Auger J, Bret N, Chevreste A,et al. [The French linguistic validation of the Ureteric StentSymptom Questionnaire (USSQ)]. Prog Urol 2010; 20:210e3 [Article in French].
doi: 10.1364/AO.49.000739
pmid: 20230943
[40]
Tanidir Y, Mangir N, Sahan A, Sulukaya M . Turkish version ofthe Ureteral Stent Symptoms Questionnaire: linguistic andpsychometric validation. World J Urol 2017; 35:1149e54.
doi: 10.1007/s00345-016-1958-4
pmid: 27766388
[41]
El-Nahas AR, Elsaadany MM, Tharwat M, Mosbah A, Metwally AH, Hawary A , et al. Validation of the Arabic linguisticversion of the Ureteral Stent Symptoms Questionnaire. Arab J Urol 2014; 12:290e3.
doi: 10.1016/j.aju.2014.08.001
pmid: 4434880
[42]
Lee C, Kuskowski M, Premoli J, Skemp N, Monga M . Randomizedevaluation of ureteral stents using validated symptom questionnaire. J Endourol 2005; 19:990e3.
doi: 10.1089/end.2005.19.990
pmid: 16253066
[43]
Zumstein V, Betschart P, Albrich WC, Buhmann MT, Ren Q, Schmid HP , et al. Biofilm formation on ureteral stents -incidence, clinical impact, and prevention. Swiss Med Wkly2017; 147:w14408.
Akay AF, Aflay U, Gedik A, Sahin H, Bircan MK . Risk factors forlower urinary tract infection and bacterial stent colonizationin patients with a double J ureteral stent. Int Urol Nephrol2007; 39:95e8.
doi: 10.1007/s11255-006-9150-1
pmid: 17171409
[46]
Moltzahn F, Haeni K, Birkhäuser FD, Roth B, Thalmann GN, Zehnder P . Peri-interventional antibiotic prophylaxis only vs.continuous low-dose antibiotic treatment in patients with JJstents: a prospective randomised trial analysing the effect onurinary tract infections and stent-related symptoms. BJU Int2013; 111:289e95.
[47]
Sighinolfi MC, Sighinolfi GP, Galli E, Micali S, Ferrari N, Mofferdin A , et al. Chemical and mineralogical analysis ofureteral stent encrustation and associated risk factors. Urology 2015; 86:703e6.
doi: 10.1016/j.urology.2015.05.015
pmid: 26740145
[48]
Broomfield RJ, Morgan SD, Khan A, Stickler DJ . Crystallinebacterial biofilm formation on urinary catheters by ureaseproducingurinary tract pathogens: a simple method of control. J Med Microbiol 2009; 58:1367e75.
doi: 10.1099/jmm.0.012419-0
pmid: 19556373
[49]
El-Faqih SR, Shamsuddin AB, Chakrabarti A, Atassi R, Kardar AH, Osman MK , et al. Polyurethane internal ureteralstents in treatment of stone patients: morbidity related toindwelling times. J Urol 1991; 146:1487e91.
doi: 10.1111/j.1464-410X.1991.tb15440.x
pmid: 1942324
[50]
Kawahara T, Ito H, Terao H, Yoshida M, Matsuzaki J . Ureteralstent encrustation, incrustation, and coloring: morbidityrelated to indwelling times. J Endourol 2012; 26:178e82.
doi: 10.1089/end.2011.0385
pmid: 22007916
[51]
Monga M, Klein E, Castañeda-Zúñiga WR, Thomas R . Theforgotten indwelling ureteral stent: a urological dilemma. JUrol 1995; 153:1817e9.
doi: 10.1097/00005392-199506000-00020
pmid: 7752325
[52]
Singh V, Srinivastava A, Kapoor R, Kumar A . Can thecomplicated forgotten indwelling ureteric stents be lethal? Int Urol Nephrol 2005; 37:541e6.
doi: 10.1007/s11255-004-4704-6
pmid: 16307339
Sancaktutar AA, Söylemez H, Bozkurt Y, Penbegül N, Atar M . Treatment of forgotten ureteral stents: how much does itreally cost? A cost-effectiveness study in 27 patients. UrolRes 2012; 40:317e25.
doi: 10.1007/s00240-011-0409-3
pmid: 21833788
[55]
Lynch MF, Ghani KR, Frost I, Anson KM . Preventing theforgotten ureteral stent: implementation of a web-basedstent registry with automatic recall application. Urology2007; 70:423e6.
doi: 10.1016/j.urology.2007.04.022
pmid: 17707893
[56]
Sancaktutar AA, Tepeler A, Söylemez H, Penbegül N, Atar M, Bozkurt Y , et al. A solution for medical and legal problemsarising from forgotten ureteral stents: initial results from areminder short message service (SMS). Urol Res 2012; 40:253e8.
doi: 10.1016/S1569-9056(11)60689-1
pmid: 21792673
[57]
Ziemba JB, Ludwig WW, Ruiz L, Carvalhal E, Matlaga BR . Preventing the forgotten ureteral stent by using a mobilepoint-of-care application. J Endourol 2017; 31:719e24.
doi: 10.1089/end.2017.0118
pmid: 28443681
[58]
Betschart P, Zumstein V, Piller A, Schmid HP, Abt D . Preventionand treatment of symptoms associated withindwelling ureteral stents: a systematic review. Int J Urol2017; 24:250e9.
doi: 10.1111/iju.13311
pmid: 28236323
[59]
Mardis HK, Kroeger RM, Morton JJ, Donovan JM . Comparativeevaluation of materials used for internal ureteral stents. JEndourol 1993; 7:105e15.
doi: 10.1089/end.1993.7.105
pmid: 8518822
[60]
Denstedt JD, Wollin TA, Reid G . Biomaterials used in urology:current issues of biocompatibility, infection, and encrustation. J Endourol 1998; 12:493e500.
doi: 10.1089/end.1998.12.493
pmid: 9895250
[61]
Marx M, Bettmann MA, Bridge S, Brodsky G, Boxt LM, Richie JP . The effects of various indwelling ureteral catheter materialson the normal canine ureter. J Urol 1988; 139:180e5.
pmid: 3336093
[62]
Gorman SP, Garvin CP, Quigley F, Jones DS . Design and validationof a dynamic flow model simulating encrustation ofbiomaterials in the urinary tract. J Pharm Pharmacol 2003; 55:461e8.
doi: 10.1211/002235702856
pmid: 12803767
[63]
Joshi HB, Chitale SV, Nagarajan M, Irving SO, Browning AJ, Biyani CS , et al. A prospective randomized single-blindcomparison of ureteral stents composed of firm and softpolymer. J Urol 2005; 174:2303e6.
doi: 10.1097/01.ju.0000181815.63998.5f
pmid: 16280829
[64]
Lennon GM, Thornhill JA, Sweeney PA, Grainger R , McDermott TE, Butler MR. “Firm” versus “soft” double pigtailureteric stents: a randomised blind comparative trial. EurUrol 1995; 28:1e5.
[65]
Park HK, Paick SH, Kim HG, Lho YS, Bae S . The impact ofureteral stent type on patient symptoms as determined bythe ureteral stent symptom questionnaire: a prospective,randomized, controlled study. J Endourol 2015; 29:367e71.
[66]
Davenport K, Kumar V, Collins J, Melotti R, Timoney AG, Keeley FX . New ureteral stent design does not improve patientquality of life: a randomized, controlled trial. J Urol2011; 185:175e8.
[67]
Brewer AV, Elbahnasy AM, Bercowsky E, Maxwell KL, Shalhav AL, Kahn SA , et al. Mechanism of ureteral stent flow:a comparative in vivo study. J Endourol 1999; 13:269e71.
doi: 10.1089/end.1999.13.269
pmid: 10405904
[68]
Lam JS, Gupta M . Update on ureteral stents. Urology 2004; 64:9e15.
[69]
Stoller ML, Schwartz BF, Frigstad JR, Norris L, Park JB, Magliochetti MJ . An in vitro assessment of the flowcharacteristics of spiral-ridged and smooth-walled JJureteric stents. BJU Int 2000; 85:628e31.
doi: 10.1046/j.1464-410x.2000.00489.x
pmid: 10759654
[70]
Olweny EO, Portis AJ, Afane JS, Brewer AV, Shalhav AL, Luszczynski K , et al. Flow characteristics of 3 unique ureteralstents: investigation of a Poiseuille flow pattern. J Urol 2000; 164:2099e103.
doi: 10.1016/S0022-5347(05)66977-7
pmid: 11061935
[71]
Gerber R, Nitz C, Studer UE, Danuser H . Spiral stent versusstandard stent in patients with midsize renal stones treatedwith extracorporeal shock wave lithotripsy: which stentworks better? A prospective randomized trial. J Urol 2004; 172:965e6.
doi: 10.1097/01.ju.0000134544.78768.12
pmid: 15311010
[72]
Chua ME, Morales Jr ML . Spontaneous fracture of indwellingpolyurethane ureteral stents: a case series and review ofliterature. Can Urol Assoc J 2012; 6:386e92.
doi: 10.5489/cuaj.12013
pmid: 23093634
[73]
Kim H-H, Choi YH, Lee SB, Baba Y, Kim KW, Suh SH . Numericalanalysis of urine flow through the side holes of a double Jstent in a ureteral stenosis. Technol Health Care 2017; 25:63e72.
doi: 10.3233/THC-171307
pmid: 28582893
[74]
Erturk E, Sessions A, Joseph JV . Impact of ureteral stentdiameter on symptoms and tolerability. J Endourol 2003; 17:59e62.
doi: 10.1063/1.359867
pmid: 12689395
[75]
Damiano R, Autorino R, De Sio M, Cantiello F, Quarto G , Perdonà S, et al. Does the size of ureteral stent impact urinarysymptoms and quality of life? A prospective randomizedstudy. Eur Urol 2005; 48:673e8.
doi: 10.1016/j.eururo.2005.06.006
pmid: 16039775
[76]
Lange D, Hoag NA, Poh BK, Chew BH . Drainage characteristicsof the 3F MicroStent using a novel film occlusion anchoringmechanism. J Endourol 2011; 25:1051e6.
doi: 10.1089/end.2010.0722
pmid: 21568690
[77]
Al-Kandari AM, Al-Shaiji TF, Shaaban H, Ibrahim HM, Elshebiny YH, Shokeir AA . Effects of proximal and distal endsof double-J ureteral stent position on postprocedural symptomsand quality of life: a randomized clinical trial. JEndourol 2007; 21:698e702.
doi: 10.1089/end.2007.9949
pmid: 17705753
[78]
Giannarini G, Keeley FX, Valent F, Manassero F, Mogorovich A, Autorino R , et al. Predictors of morbidity inpatients with indwelling ureteric stents: results of a prospectivestudy using the validated Ureteric Stent SymptomsQuestionnaire. BJU Int 2011; 107:648e54.
doi: 10.1111/j.1464-410X.2010.09482.x
pmid: 20590539
[79]
El-Nahas AR, El-Assmy AM, Shoma AM, Eraky I, El-Kenawy MR, El-Kappany HA . Self-retaining ureteral stents: analysis offactors responsible for patients’ discomfort. J Endourol 2006; 20:33e7.
doi: 10.1089/end.2006.20.33
pmid: 16426130
[80]
Breau RH, Norman RW . Optimal prevention and managementof proximal ureteral stent migration and remigration. J Urol2001; 166:890e3.
doi: 10.1016/S0022-5347(05)65858-2
pmid: 11490240
[81]
Barrett K, Foell K, Lantz A, Ordon M, Lee JY, Pace KT , et al. Best stent length predicted by simple CT measurementrather than patient height. J Endourol 2016; 30:1029e32.
doi: 10.1089/end.2016.0105
pmid: 27338649
[82]
Novaes HFF, Leite PCS, Almeida RA, Sorte NCB, Barroso U . Analysis of ureteral length in adult cadavers. Int Braz J Urol2013; 39:248e56.
doi: 10.1590/S1677-5538.IBJU.2013.02.14
pmid: 23683671
[83]
Barrett K, Ghiculete D, Sowerby RJ, Farcas M, Pace KT , Honey RJD. Intraoperative radiographic determination ofureteral length as a method of determining ideal stentlength. J Endourol 2017; 31:S101e5.
doi: 10.1089/end.2016.0709
pmid: 28306331
[84]
Shrewsberry AB, Al-Qassab U, Goodman M, Petros JA, Sullivan JW, Ritenour CWM , et al. A t20% adjustment in thecomputed tomography measured ureteral length is an accuratepredictor of true ureteral length before ureteral stentplacement. J Endourol 2013; 27:1041e5.
[85]
Palmer JS, Palmer LS . Determining the proper stent length touse in children: age plus 10. J Urol 2007; 178:1566e9.
doi: 10.1016/j.juro.2007.03.191
pmid: 17707050
[86]
Calvert RC, Wong KY, Chitale SV, Irving SO, Nagarajan M, Biyani CS , et al. Multi-length or 24 cm ureteric stent? A multicentrerandomised comparison of stent-related symptomsusing a validated questionnaire. BJU Int 2013; 111:1099e104.
doi: 10.1111/j.1464-410X.2012.11388.x
pmid: 22882647
[87]
Liatsikos EN, Gershbaum D, Kapoor R, Fogarty J, Dinlenc CZ, Bernardo NO , et al. Comparison of symptoms related topositioning of double-pigtail stent in upper pole versus renalpelvis. J Endourol 2001; 15:299e302.
doi: 10.1089/089277901750161854
pmid: 11339397
[88]
Lingeman JE, Preminger GM, Goldfischer ER, Krambeck AE . Assessing the impact of ureteral stent design on patientcomfort. J Urol 2009; 181:2581e7.
doi: 10.1016/j.juro.2009.02.019
pmid: 3164810
[89]
Dunn MD, Portis AJ, Kahn SA, Yan Y, Shalhav AL, Elbahnasy AM , et al. Clinical effectiveness of new stentdesign: randomized single-blind comparison of tail anddouble-pigtail stents. J Endourol 2000; 14:195e202.
doi: 10.1089/end.2000.14.195
pmid: 10772515
[90]
Vogt B, Desgrippes A, Desfemmes FN . Changing the doublepigtailstent by a new suture stent to improve patient’squality of life: a prospective study. World J Urol 2015; 33:1061e8.
[91]
Chew BH, Rebullar KA, Harriman D , McDougall E, Paterson RF,Lange D. Percuflex helical ureteral stents significantly reducepatient analgesic requirements compared to control stents. JEndourol 2017; 31:1321e5.
doi: 10.1089/end.2017.0349
pmid: 29048209
[92]
Yossepowitch O, Lifshitz DA, Dekel Y, Ehrlich Y, Gur U, Margel D , et al. Assessment of vesicoureteral reflux in patientswith self-retaining ureteral stents: implications forupper urinary tract instillation. J Urol 2005; 173:890e3.
doi: 10.1097/01.ju.0000147747.89028.64
pmid: 15711312
[93]
Ritter M, Krombach P, Knoll T, Michel MS, Haecker A . Initialexperience with a newly developed antirefluxive ureterstent. Urol Res 2012; 40:349e53.
doi: 10.1007/s00240-011-0415-5
pmid: 21850408
[94]
Ecke TH, Bartel P, Hallmann S, Ruttloff J . Evaluation ofsymptoms and patients’ comfort for JJ-ureteral stents withand without antireflux-membrane valve. Urology 2010; 75:212e6.
doi: 10.1016/j.urology.2009.07.1258
pmid: 19819529
[95]
Kim HW, Park CJ, Seo S, Park Y, Lee JZ, Shin DG , et al. Evaluation of a polymeric flap valve-attached ureteral stentfor preventing vesicoureteral reflux in elevated intravesicalpressure conditions: a pilot study using a porcine model. JEndourol 2016; 30:428e32.
[96]
Desgrandchamps F, Moulinier F, Daudon M, Teillac P , LeDuc A. An in vitro comparison of urease-induced encrustationof JJ stents in human urine. Br J Urol 1997; 79:24e7.
doi: 10.1046/j.1464-410X.1997.27517.x
pmid: 9052477
[97]
John T, Rajpurkar A, Smith G, Fairfax M, Triest J . Antibioticpretreatment of hydrogel ureteral stent. J Endourol 2007; 21:1211e6.
[98]
Gorman SP, Tunney MM, Keane PF, Van Bladel K, Bley B . Characterization and assessment of a novel poly(ethyleneoxide)/polyurethane composite hydrogel (Aquavene) as aureteral stent biomaterial. J Biomed Mater Res 1998; 39:642e9.
[99]
Stickler DJ, Evans A, Morris N, Hughes G . Strategies for thecontrol of catheter encrustation. Int J Antimicrob Agents2002; 19:499e506.
doi: 10.1016/S0924-8579(02)00091-2
pmid: 12135840
[100]
Tunney MM, Gorman SP . Evaluation of a poly(vinylpyrollidone)-coated biomaterial for urological use. Biomaterials2002; 23:4601e8.
doi: 10.1016/S0142-9612(02)00206-5
pmid: 12322981
[101]
Cauda F, Cauda V, Fiori C, Onida B, Garrone E . Heparincoating on ureteral Double J stents prevents encrustations:an in vivo case study. J Endourol 2008; 22:465e72.
doi: 10.1089/end.2007.0218
pmid: 18307380
[102]
Lange D, Elwood CN, Choi K, Hendlin K, Monga M, Chew BH . Uropathogen interaction with the surface of urological stentsusing different surface properties. J Urol 2009; 182:1194e200.
doi: 10.1016/j.juro.2009.05.008
pmid: 19625060
[103]
Laube N, Kleinen L, Bradenahl J, Meissner A . Diamond-likecarbon coatings on ureteral stentsda new strategy fordecreasing the formation of crystalline bacterial biofilms? JUrol 2007; 177:1923e7.
doi: 10.1016/j.juro.2007.01.016
pmid: 17437849
[104]
Cadieux PA, Chew BH, Knudsen BE, Dejong K, Rowe E, Reid G , et al. Triclosan loaded ureteral stents decrease proteusmirabilis 296 infection in a rabbit urinary tract infectionmodel. J Urol 2006; 175:2331e5.
doi: 10.1016/S0022-5347(06)00252-7
pmid: 16697868
[105]
Cadieux PA, Chew BH, Nott L, Seney S, Elwood CN, Wignall GR , et al. Use of triclosan-eluting ureteral stents inpatients with long-term stents. J Endourol 2009; 23:1187e94.
doi: 10.1089/end.2008.0437
pmid: 19538062
[106]
Mendez-Probst CE, Goneau LW , MacDonald KW, Nott L, Seney S, Elwood CN, et al. The use of triclosan eluting stentseffectively reduces ureteral stent symptoms: a prospectiverandomized trial. BJU Int 2012; 110:749e54.
doi: 10.1111/j.1464-410X.2011.10903.x
pmid: 22313688
[107]
Krambeck AE, Walsh RS, Denstedt JD, Preminger GM, Li J, Evans JC , et al. A novel drug eluting ureteral stent: a prospective,randomized, multicenter clinical trial to evaluatethe safety and effectiveness of a ketorolac loaded ureteralstent. J Urol 2010; 183:1037e42.
doi: 10.1016/j.juro.2009.11.035
pmid: 20092835
[108]
Beiko DT, Watterson JD, Knudsen BE, Nott L, Pautler SE, Brock GB , et al. Double-blind randomized controlled trialassessing the safety and efficacy of intravesical agents forureteral stent symptoms after extracorporeal shockwavelithotripsy. J Endourol 2004; 18:723e30.
doi: 10.1089/end.2004.18.723
pmid: 15659891
[109]
El-Nahas AR, Lachine M, Elsawy E, Mosbah A, El-Kappany H . Arandomized controlled trial comparing antimicrobial (silversulfadiazine)-coated ureteral stents with non-coated stents. Scand J Urol 2017: 1e5.
doi: 10.1080/21681805.2017.1376353
pmid: 28931344
[110]
Yang L, Whiteside S, Cadieux PA, Denstedt JD . Ureteral stenttechnology: drug-eluting stents and stent coatings. Asian JUrol 2015; 2:194e201.
doi: 10.1016/j.ajur.2015.08.006
[111]
Sigala S, Dellabella M, Milanese G, Fornari S, Faccoli S, Palazzolo F , et al. Evidence for the presence of alpha1adrenoceptor subtypes in the human ureter. Neurourol Urodyn2005; 24:142e8.
doi: 10.1002/nau.20097
pmid: 15690361
[112]
Sigala S, Peroni A, Mirabella G, Fornari S, Palazzolo F, Pezzotti G , et al. Alpha 1 adrenoceptor subtypes in humanurinary bladder: sex and regional comparison. Life Sci 2004; 76:417e27.
doi: 10.1016/j.lfs.2004.09.008
pmid: 15530504
[113]
Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM . Is there a role for alpha1-blockers intreating double-J stent-related symptoms? Urology 2006; 67:35e9.
doi: 10.1016/j.urology.2005.07.038
pmid: 16413328
[114]
He F, Man LB, Li GZ, Liu N . Efficacy of a-blocker in improvingureteral stent-related symptoms: a meta-analysis of bothdirect and indirect comparison. Drug Des Dev Ther 2016; 10:1783e93.
doi: 10.2147/DDDT.S103195
pmid: 40
[115]
Zhang L, Li J, Pan M, Han W, Liu S, Xiao Y . Doxazosin oralintake therapy to relieve stent-related urinary symptoms andpain: a prospective, randomized, controlled study. Int Braz JUrol 2016; 42:727e33.
doi: 10.1590/S1677-5538.IBJU.2015.0570
pmid: 27564283
[116]
Wang J, Zhang X, Zhang T, Mu J, Bai B, Lei Y . The role ofsolifenacin, as monotherapy or combination with tamsulosinin ureteral stent-related symptoms: a systematic review andmeta-analysis. World J Urol 2017; 35:1669e80.
doi: 10.1007/s00345-017-2051-3
pmid: 28550362
[117]
Zhang YM, Chu P, Wang WJ . PRISMA-combined a-blockers andantimuscarinics for ureteral stent-related symptoms: ameta-analysis. Medicine (Baltim) 2017; 96:e6098.
doi: 10.1097/MD.0000000000006098
[118]
Sur RL, Haleblian GE, Cantor DA, Springhart WP, Albala DM, Preminger GM . Efficacy of intravesical ropivacaine injectionon urinary symptoms following ureteral stenting: a randomized,controlled study. J Endourol 2008; 22:473e8.
doi: 10.1016/S0024-2829(03)00012-4
pmid: 18290733
[119]
Gupta M, Patel T, Xavier K, Maruffo F, Lehman D, Walsh R , et al. Prospective randomized evaluation of periureteralbotulinum toxin type A injection for ureteral stent painreduction. J Urol 2010; 183:598e602.
doi: 10.1016/j.juro.2009.10.021
pmid: 20018320
[120]
Abt D, Warzinek E, Schmid HP, Haile SR, Engeler DS . Influenceof patient education on morbidity caused by ureteralstents. Int J Urol 2015; 22:679e83.
doi: 10.1111/iju.12782
pmid: 25882159
[121]
Okullo A, Yuminaga Y, Ziaziaris W, Ende D, Lau H, Brooks A , et al. Comparison of cost of care for tethered versus nontetheredureteric stents in the management of uncomplicatedupper urinary tract stones. ANZ J Surg 2017; 87:505e8.
doi: 10.1111/ans.13945
pmid: 28370915
[122]
Barnes KT, Bing MT, Tracy CR . Do ureteric stent extractionstrings affect stent-related quality of life or complicationsafter ureteroscopy for urolithiasis: a prospective randomisedcontrol trial. BJU Int 2014; 113:605e9.
doi: 10.1111/bju.12541
pmid: 24765679
[123]
Althaus AB, Li K, Pattison E, Eisner B, Pais V, Steinberg P . Rate ofdislodgment of ureteral stents when using an extraction stringafter endoscopic urological surgery. J Urol 2015; 193:2011e4.
doi: 10.1016/j.juro.2014.12.087
pmid: 25541339
[124]
Fröhlich M, Fehr J, Sulser T, Eberli D, Mortezavi A . Extractionstrings for ureteric stents: is there an increased risk for urinarytract infections? Surg Infect (Larchmt) 2017; 18:936e40.
doi: 10.1089/sur.2017.165
pmid: 28976816
[125]
Freifeld Y, Goldin D, Khalili L, Friedman B, Boyarsky L, Klein I , et al. Does the use of ureteral stents with extractionstrings increase urinary infection rates? Int Urol Nephrol2017; 49:763e7.
doi: 10.1007/s11255-017-1533-y
pmid: 28185106
[126]
Loh-Doyle JC, Low RK, Monga M, Nguyen MM . Patient experiencesand preferences with ureteral stent removal. JEndourol 2015; 29:35e40.
doi: 10.1016/j.juro.2014.02.697
pmid: 25019375
[127]
Kim DJ, Son JH, Jang SH, Lee JW, Cho DS, Lim CH . Rethinkingof ureteral stent removal using an extraction string; whatpatients feel and what is patients’ preference? : a randomizedcontrolled study. BMC Urol 2015; 15:121.
doi: 10.1186/s12894-015-0114-6
pmid: 4675013
[128]
Macaluso JN, Deutsch JS, Goodman JR, Appell RA, Prats LJ, Wahl P . The use of the Magnetip double-J ureteral stent inurological practice. J Urol 1989; 142:701e3.
doi: 10.1111/j.1464-410X.1989.tb06031.x
pmid: 2671410
[129]
Taylor WN , McDougall IT. Minimally invasive ureteral stentretrieval. J Urol 2002; 168:2020e3.
[130]
Rassweiler MC, Michel MS, Ritter M, Honeck P . Magneticureteral stent removal without cystoscopy: a randomizedcontrolled trial. J Endourol 2017; 31:762e6.
doi: 10.1089/end.2017.0051
[131]
Wang J, Feng J, Hu W, Song Y, Xu X, Fan M , et al. Preclinicalevaluation of a newly designed ureteral stent and magneticretrieval catheter for minimally invasive stent removal. Urology 2014; 84:960e6.
doi: 10.1016/j.urology.2014.06.024
pmid: 25151437
[132]
Lingeman JE, Preminger GM, Berger Y, Denstedt JD, Goldstone L, Segura JW , et al. Use of a temporary ureteraldrainage stent after uncomplicated ureteroscopy:results from a phase II clinical trial. J Urol 2003; 169:1682e8.
doi: 10.1097/01.ju.0000055600.18515.a1
pmid: 12686808
[133]
Chew BH, Paterson RF, Clinkscales KW, Levine BS, Shalaby SW, Lange D . In vivo evaluation of the third generationbiodegradable stent: a novel approach to avoiding theforgottenstent syndrome. J Urol 2013; 189:719e25.
doi: 10.1016/j.juro.2013.02.3189
pmid: 22982432
[134]
Barros AA, Rita A, Duarte C, Pires RA, Sampaio-Marques B, Ludovico P , et al. Bioresorbable ureteral stents from naturalorigin polymers. J Biomed Mater Res Part B Appl Biomater2015; 103:608e17.
doi: 10.1002/jbm.b.33237
pmid: 24965000
[135]
Barros AA, Oliveira C, Reis RL, Lima E, Duarte ARC . In vitroand ex vivo permeability studies of paclitaxel and doxorubicinfrom drug-eluting biodegradable ureteral stents. JPharmacol Sci 2017; 106:1466e74.
doi: 10.1016/j.xphs.2017.02.023
pmid: 28257819
[136]
Barros AA, Oliveira C, Reis RL, Lima E, Rita A, Duarte C . Ketoprofen-eluting biodegradable ureteral stents by CO2impregnation: in vitro study. Int J Pharm 2015; 495:651e9.
doi: 10.1016/j.ijpharm.2015.08.040
pmid: 26392243
Christopher Hartman, Nikhil Gupta, David Leavitt, David Hoenig, Zeph Okeke, Arthur Smith. Advances in percutaneous stone surgery[J]. Asian Journal of Urology, 2015, 2(1): 26
-32
.
